Webinar: Bringing Science to the Marketplace

The Office of Cancer Centers Learning Series Webinar Presents: Bringing Science to the Marketplace: The NCI’s Small Business Innovation Research Program

Do you have a small business that’s bringing advances in technology, treatments, and imaging to the forefront of cancer care?

If so, we encourage you to join NCI’s Office of Cancer Centers for a FREE webinar Thursday, September 8, from 2:00 to 3:30 pm, ET, to learn how to tap into the resources of the National Cancer Institute’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs, two of the largest sources of early-stage technology financing in the United States.

During this webinar, NCI SBIR Development Center leaders will discuss new and existing initiatives to help small businesses further commercialize their innovations, including funding opportunities such as the recently announced $8M in contract funding opportunities, and the Phase II Bridge Award. Additionally, an SBIR grantee will share how he strategically leveraged the SBIR Program to help raise investor funding and advance his company’s cancer technology to the next stage of development.

More SBIR/STTR News:

August 30, 2011: NIH Offers Commercialization Assistance Program to SBIR Phase II Awardees.

NIH announces the availability of a Commercialization Assistance Program (CAP) for its SBIR Phase II awardees from the past five years. This program is aimed at assisting participants evaluate their commercialization options based on their specific SBIR-supported technologies and to develop a solid market-entry strategic plan. For details, please check the NIH Guide Notice NOT-OD-11-102
and also review the full program description and instructions on how to apply at http://grants.nih.gov/grants/funding/cap/index.htm.
Applications deadline extended to September 12, 2011.

August 25, 2011: NIH/CDC SBIR Contract Solicitation Now Available. The PHS 2012-1 SBIR Contract Solicitation is now open. (Receipt date: November 7, 2011. For additional information, see the 08/25/2011 NIH Guide Notice.